摘要
目的探讨醒脑静注射液治疗脑卒中的临床疗效。方法收集2010年1月至2014年1月我院收治的脑卒中66例患者资料,将患者随机分为两组,对照组患者给予临床常规治疗;研究组患者在对照组基础上加用醒脑静注射液,比较两组脑卒中患者临床疗效。结果经治疗后,研究组患者的临床治疗总有效率为93.9%,明显高于对照组的75.8%,差异有统计学意义(P<0.05)。结论脑卒中患者在常规治疗基础上加用醒脑静注射液等进行治疗,实现靶向神经血管单元保护作用,可明显提高其临床疗效,保障患者的生活质量及生命安全。
Objective To investigate the clinical effect of Xingnaojing Injection in the treatment of stroke.Methods 66 stroke patients in 2010 January to 2014 January were selected in our hospital patients,randomly divided into two groups,control ed clinical routine treatment measures to give patients;patients in study group treated with Xingnaojing Injection on the basis of the control group,compared two groups of clinical curative effect of stroke patients.Results After treatment,the clinical treatment of patients with a total effective rate of 93.9%,significantly higher than 75.8%in the control group,the difference was statistical y significant（P〈0.05）.Conclusion Stroke patients with targeting vascular protection unit nerve can significantly improve their clinical efficacy with Xingnaojing injection and other drugs on the basis of conventional treatment,guarantee the quality and safety of life of life of the patients.
出处
《中国药物经济学》
2015年第3期51-52,共2页
China Journal of Pharmaceutical Economics
关键词
脑卒中
靶向神经血管单元
临床疗效
Stroke
Targeted neurovascular unit
Clinical Curative effct
